Suggestion of BRCA1 c.5339T>C (p.L1780P) variant confer from ‘unknown significance’ to ‘Likely pathogenic’ based on clinical evidence in Korea-Reference-Cited by-同舟云学术

Suggestion of BRCA1 c.5339T>C (p.L1780P) variant confer from ‘unknown significance’ to ‘Likely pathogenic’ based on clinical evidence in Korea

Published:2017-06 Issue: Volume:33 Page:109-116
ISSN:0960-9776
Container-title:The Breast
language:en
Short-container-title:The Breast

Author:

Ryu Jai Min,Kang Goeun,Nam Seok Jin,Kim Seok Won,Yu Jonghan,Lee Se Kyung,Bae Soo Youn,Park Sungmin,Paik Hyun-June,Kim Jong-Won,Park Sung-Shin,Lee Jeong Eon,Kim Sung-Won

Funder

Korea Health Technology R&D Project

Korea Health Industry Development Institute

Ministry of Health & Welfare, Republic of Korea

Publisher

Elsevier BV

Subject

General Medicine,Surgery

Reference32 articles.

1. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1;Miki;Science,1994

2. Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium;Easton;Am J Hum Genet,1995

3. SEER cancer statistics review, 1975–2011;Howlader,2014

4. Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals;Frank;J Clin Oncol,2002

5. BRCA1/2 sequence variants of uncertain significance: a primer for providers to assist in discussions and in medical management;Lindor;Oncologist,2013

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reversion of pathogenic BRCA1 L1780P mutation confers resistance to PARP and ATM inhibitor in breast cancer;iScience;2024-08

2. Reclassifying BRCA1 c.4358-2A > G and BRCA2 c.475 + 5G > C variants from “Uncertain Significance” to “Pathogenic” based on minigene assays and clinical evidence;Journal of Cancer Research and Clinical Oncology;2024-02-01

3. Discovery of BRCA1/BRCA2 founder variants by haplotype analysis;Cancer Genetics;2022-08

4. Molecular Characterization of BRCA1 c.5339T>C Missense Mutation in DNA Damage Response of Triple-Negative Breast Cancer;Cancers;2022-05-13

5. BRCA1/2 variants of unknown significance in hereditary breast and ovarian cancer (HBOC) syndrome: Looking for the hidden meaning;Critical Reviews in Oncology/Hematology;2022-04